Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127688171 | 12768817 | 1 | I | 20160601 | 20160921 | 20160921 | PER | US-JAZZ-2016-US-010248 | JAZZ | 0.00 | F | Y | 0.00000 | 20160921 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127688171 | 12768817 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.5 G, BID | 21196 | 3.5 | G | ORAL SOLUTION | |||||||
| 127688171 | 12768817 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 127688171 | 12768817 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | 21196 | 4 | G | ORAL SOLUTION | |||||||
| 127688171 | 12768817 | 4 | SS | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 5 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 127688171 | 12768817 | 6 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 7 | C | Probiotic | PROBIOTICS NOS | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 8 | C | Centrum silver | MINERALSVITAMINS | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 9 | C | RESTASIS | CYCLOSPORINE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 10 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 11 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 12 | C | NUVIGIL | ARMODAFINIL | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 13 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 14 | C | BUSPIRONE HCL | BUSPIRONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 15 | C | ECONAZOLE NITRATE. | ECONAZOLE NITRATE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 16 | C | Hydroxyzine hcl | HYDROXYZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 17 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 18 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 127688171 | 12768817 | 19 | C | METOPROLOL. | METOPROLOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127688171 | 12768817 | 1 | Narcolepsy |
| 127688171 | 12768817 | 4 | Product used for unknown indication |
| 127688171 | 12768817 | 5 | Product used for unknown indication |
| 127688171 | 12768817 | 19 | Blood pressure measurement |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127688171 | 12768817 | Anxiety | |
| 127688171 | 12768817 | Drug ineffective | |
| 127688171 | 12768817 | Pre-existing condition improved |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127688171 | 12768817 | 1 | 201404 | 201410 | 0 | |
| 127688171 | 12768817 | 2 | 201410 | 201507 | 0 | |
| 127688171 | 12768817 | 3 | 201507 | 0 |